GlaxoSmithKline (GSK) has lost a contract to Pfizer to supply millions of doses of its RSV vaccine to the UK, with Pfizer set to supply over 4.9 million doses to England and Northern Ireland starting in July. This decision by the UK government is a setback for GSK, as Pfizer gains ground in the RSV vaccine race. In the US, GSK's market position is challenged as health officials recommend restricting vaccination with its RSV shot to older and more at-risk individuals, leading to a 6% drop in GSK's shares.
GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots https://t.co/g1si3efFuQ
$GSK (-1.6% pre) GSK shares slide after US health agency narrows scope of RSV shots - Reuters https://t.co/twYNmr4q7C
GSK shares slide as US CDC limits RSV vaccine scope; analysts weigh in https://t.co/N9Wq42wtPy https://t.co/4fAby0A9zZ
GSK slides 6% after US CDC narrows scope of RSV shots https://t.co/YCR2wdBcda https://t.co/I0O8WGxreg
GSK stock falls more at London open following RSV vaccination news https://t.co/DtdIlHpXlr
🔵 GSK SLIDES 6% AFTER US CDC NARROWS SCOPE OF RSV SHOTS GSK's shares dropped more than 6% on Thursday, a day after a U.S. public health agency narrowed its usage recommendation for all respiratory syncytial virus (RSV) vaccines and held off on recommending their use for those… https://t.co/uJ1SZb5ZST
GSK slumps after US health officials recommended restricting vaccination with its RSV shot to people who are older and more at risk https://t.co/IOmOOOQmsI
US advisers to consider RSV shots as drugmaker GSK looks to keep market lead https://t.co/mRSqlTIsrE https://t.co/mRSqlTIsrE
US advisers to consider RSV shots as GSK looks to keep market lead https://t.co/PJyOfenefe https://t.co/PJyOfenefe
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot https://t.co/rpOCzMvnNx
“The UK government has selected Pfizer to supply millions of respiratory syncytial virus (RSV) vaccine doses, snubbing local pharma company GSK and its competing product’ https://t.co/uAPXkLMAWE
Rallying in RSV vaccine race, Pfizer gains contract win over GSK in the UK https://t.co/BMsKN18EP5
Another win for GSK in RSV... as competitors Pfizer and Sanofi have struggled. https://t.co/sRBV5DLBi1
SCOOP: GSK has lost out to Pfizer on a contract to supply millions of doses of its blockbuster RSV vaccine to the UK in a setback for the local pharma giant. Pfizer will supply over 4.9 million doses to England and Northern Ireland starting in July. https://t.co/YCqdwI1otw
GSK has lost out to Pfizer on a contract to supply millions of doses of its blockbuster RSV vaccine to the UK in a setback for the local pharma giant https://t.co/CvENUaPEIA